CPCI Statistics

Total Valuation

Kahira Pharmaceuticals & Chemical Industries Company has a market cap or net worth of EGP 1.26 billion. The enterprise value is 1.39 billion.

Market Cap	1.26B
Enterprise Value	1.39B

Important Dates

The last earnings date was Tuesday, October 15, 2024.

Earnings Date	Oct 15, 2024
Ex-Dividend Date	n/a

Share Statistics

Kahira Pharmaceuticals & Chemical Industries Company has 14.93 million shares outstanding.

Shares Outstanding	14.93M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	n/a
Float	2.71M

Valuation Ratios

The trailing PE ratio is 5.32.

PE Ratio	5.32
Forward PE	n/a
PS Ratio	0.91
PB Ratio	1.60
P/FCF Ratio	102.86
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.26, with an EV/FCF ratio of 113.59.

EV / Earnings	5.87
EV / Sales	1.00
EV / EBITDA	4.26
EV / EBIT	4.79
EV / FCF	113.59

Financial Position

The company has a current ratio of 2.20, with a Debt / Equity ratio of 0.34.

Current Ratio	2.20
Quick Ratio	1.31
Debt / Equity	0.34
Debt / EBITDA	0.81
Debt / FCF	21.62
Interest Coverage	17.43

Financial Efficiency

Return on equity (ROE) is 30.74% and return on invested capital (ROIC) is 18.41%.

Return on Equity (ROE)	30.74%
Return on Assets (ROA)	12.36%
Return on Capital (ROIC)	18.41%
Revenue Per Employee	717,517
Profits Per Employee	122,339
Employee Count	2,032
Asset Turnover	0.95
Inventory Turnover	2.26

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +123.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+123.94%
50-Day Moving Average	75.97
200-Day Moving Average	70.17
Relative Strength Index (RSI)	68.42
Average Volume (20 Days)	7,546

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kahira Pharmaceuticals & Chemical Industries Company had revenue of EGP 1.38 billion and earned 236.11 million in profits. Earnings per share was 15.81.

Revenue	1.38B
Gross Profit	455.57M
Operating Income	289.71M
Pretax Income	311.07M
Net Income	236.11M
EBITDA	318.85M
EBIT	289.71M
Earnings Per Share (EPS)	15.81

Full Income Statement

Balance Sheet

The company has 132.98 million in cash and 263.99 million in debt, giving a net cash position of -131.01 million or -8.77 per share.

Cash & Cash Equivalents	132.98M
Total Debt	263.99M
Net Cash	-131.01M
Net Cash Per Share	-8.77
Equity (Book Value)	786.82M
Book Value Per Share	52.68
Working Capital	621.25M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 194.23 million and capital expenditures -182.02 million, giving a free cash flow of 12.21 million.

Operating Cash Flow	194.23M
Capital Expenditures	-182.02M
Free Cash Flow	12.21M
FCF Per Share	0.82

Full Cash Flow Statement

Margins

Gross margin is 32.90%, with operating and profit margins of 20.92% and 17.05%.

Gross Margin	32.90%
Operating Margin	20.92%
Pretax Margin	22.46%
Profit Margin	17.05%
EBITDA Margin	23.02%
EBIT Margin	20.92%
FCF Margin	0.88%

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 5.95%.

Dividend Per Share	5.00
Dividend Yield	5.95%
Dividend Growth (YoY)	-9.58%
Years of Dividend Growth	n/a
Payout Ratio	38.93%
Buyback Yield	n/a
Shareholder Yield	5.95%
Earnings Yield	18.80%
FCF Yield	0.97%

Dividend Details

Stock Splits

The last stock split was on September 10, 2020. It was a forward split with a ratio of 1.25.

Last Split Date	Sep 10, 2020
Split Type	Forward
Split Ratio	1.25

Scores

Kahira Pharmaceuticals & Chemical Industries Company has an Altman Z-Score of 3.05.

Altman Z-Score	3.05
Piotroski F-Score	n/a